These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12874616)

  • 21. A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus.
    Hager J; Hansen L; Vaisse C; Vionnet N; Philippi A; Poller W; Velho G; Carcassi C; Contu L; Julier C
    Nat Genet; 1995 Mar; 9(3):299-304. PubMed ID: 7773293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-DP distribution in Shanghai Chinese--a study by polymerase chain reaction--restriction fragment length polymorphism.
    Wang FQ; al-Daccak R; Ju LY; Lethielleux P; Charron D; Loiseau P; Colombani J
    Hum Immunol; 1992 Feb; 33(2):129-32. PubMed ID: 1348742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gly40Ser polymorphism of the glucagon receptor gene is associated with central adiposity in men.
    Siani A; Iacone R; Russo O; Barba G; Russo P; Cappuccio FP; Galletti F; Strazzullo P
    Obes Res; 2001 Nov; 9(11):722-6. PubMed ID: 11707539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Gly40Ser mutation in the human glucagon receptor gene associated with NIDDM results in a receptor with reduced sensitivity to glucagon.
    Hansen LH; Abrahamsen N; Hager J; Jelinek L; Kindsvogel W; Froguel P; Nishimura E
    Diabetes; 1996 Jun; 45(6):725-30. PubMed ID: 8635644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotype Arg/Arg, but not Trp/Arg, of the Trp64Arg polymorphism of the beta(3)-adrenergic receptor is associated with type 2 diabetes and obesity in a large Japanese sample.
    Oizumi T; Daimon M; Saitoh T; Kameda W; Yamaguchi H; Ohnuma H; Igarashi M; Eguchi H; Manaka H; Tominaga M; Kato T;
    Diabetes Care; 2001 Sep; 24(9):1579-83. PubMed ID: 11522702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensinogen Met235-->Thr polymorphism in a London normotensive and hypertensive black and white population.
    Barley J; Blackwood A; Sagnella G; Markandu N; MacGregor G; Carter N
    J Hum Hypertens; 1994 Aug; 8(8):639-40. PubMed ID: 7990101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A linkage and cross-sectional study of hypertension and obesity using a poly (A) Alu-repeat polymorphism at the glucagon receptor gene locus (17q25).
    Rutherford S; Boatwright SD; Samwell GA; Morris BJ; Griffiths LR
    Clin Exp Pharmacol Physiol; 1998; 25(7-8):627-9. PubMed ID: 9673441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucagon receptor Gly40Ser amino acid variant in Sardinian hypertensive non-insulin-dependent diabetic patients. Sardinian Diabetic Genetic Study Group (SDGSG).
    Tonolo G; Melis MG; Ciccarese M; Secchi G; Atzeni MM; Li LS; Luthman H; Maioli M
    Acta Diabetol; 1997 Aug; 34(2):75-6. PubMed ID: 9325468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic beta-cell overexpression of the glucagon receptor gene results in enhanced beta-cell function and mass.
    Gelling RW; Vuguin PM; Du XQ; Cui L; Rømer J; Pederson RA; Leiser M; Sørensen H; Holst JJ; Fledelius C; Johansen PB; Fleischer N; McIntosh CH; Nishimura E; Charron MJ
    Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E695-707. PubMed ID: 19602585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects.
    Wenyi Z; Suzuki S; Hirai M; Hinokio Y; Tanizawa Y; Matsutani A; Satoh J; Oka Y
    Diabetologia; 2003 Jul; 46(7):972-6. PubMed ID: 12830381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoglycemic Effect of Combined Ghrelin and Glucagon Receptor Blockade.
    Mani BK; Uchida A; Lee Y; Osborne-Lawrence S; Charron MJ; Unger RH; Berglund ED; Zigman JM
    Diabetes; 2017 Jul; 66(7):1847-1857. PubMed ID: 28487437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Association of Gly82Ser polymorphism of receptor for advanced glycation end products gene in a type 2 diabetic Chinese population].
    Gao JX; Xu DL; Shao YH; Lao WY; Lin S; Zhang B
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):219-22. PubMed ID: 17355942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucagon receptor gene mutation (Gly40Ser) in human essential hypertension: the PEGASE study.
    Brand E; Bankir L; Plouin PF; Soubrier F
    Hypertension; 1999 Jul; 34(1):15-7. PubMed ID: 10406817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A common mtDNA polymorphism associated with variation in plasma triglyceride concentration.
    Hegele RA; Zinman B; Hanley AJ; Harris S; Connelly PW
    Am J Hum Genet; 1997 Jun; 60(6):1552-5. PubMed ID: 9199581
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors.
    Sloop KW; Cao JX; Siesky AM; Zhang HY; Bodenmiller DM; Cox AL; Jacobs SJ; Moyers JS; Owens RA; Showalter AD; Brenner MB; Raap A; Gromada J; Berridge BR; Monteith DK; Porksen N; McKay RA; Monia BP; Bhanot S; Watts LM; Michael MD
    J Clin Invest; 2004 Jun; 113(11):1571-81. PubMed ID: 15173883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid nanoparticle delivery of glucagon receptor siRNA improves glucose homeostasis in mouse models of diabetes.
    Neumann UH; Ho JSS; Chen S; Tam YYC; Cullis PR; Kieffer TJ
    Mol Metab; 2017 Oct; 6(10):1161-1172. PubMed ID: 29031717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London.
    Baker EH; Dong YB; Sagnella GA; Rothwell M; Onipinla AK; Markandu ND; Cappuccio FP; Cook DG; Persu A; Corvol P; Jeunemaitre X; Carter ND; MacGregor GA
    Lancet; 1998 May; 351(9113):1388-92. PubMed ID: 9593408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular disease and diabetes in patients with African or Asian background.
    Aambø A; Klemsdal TO
    Tidsskr Nor Laegeforen; 2017 Nov; 137(22):. PubMed ID: 29181932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal trends in cardiovascular disease risk factors among white, South Asian, Chinese and black groups in Ontario, Canada, 2001 to 2012: a population-based study.
    Chiu M; Maclagan LC; Tu JV; Shah BR
    BMJ Open; 2015 Aug; 5(8):e007232. PubMed ID: 26260346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Race and medicine.
    Holden C
    Science; 2003 Oct; 302(5645):594-6. PubMed ID: 14576420
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.